In Search for Reasons behind Helicobacter pylori Eradication Failure–Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species

Helicobacter pylori eradication is characterized by decreasing successful eradication rates. Although treatment failure is primarily associated with resistance to antibiotics, other unknown factors may influence the eradication outcome. This study aimed to assess the presence of the antibiotics resistance genes in H. pylori and the presence of Candida spp., which are proposed to be endosymbiotic hosts of H. pylori, in gastric biopsies of H. pylori-positive patients while simultaneously assessing their relationship. The detection and identification of Candida yeasts and the detection of mutations specific for clarithromycin and fluoroquinolones were performed by using the real-time PCR (RT-PCR) method on DNA extracted from 110 gastric biopsy samples of H. pylori-positive participants. Resistance rate to clarithromycin and fluoroquinolone was 52% and 47%, respectively. Antibiotic resistance was associated with more eradication attempts (p < 0.05). Candida species were detected in nine (8.18%) patients. Candida presence was associated with older age (p < 0.05). A high rate of antibiotic resistance was observed, while Candida presence was scarce, suggesting that endosymbiosis between H. pylori and Candida may not be a major contributing factor to the eradication failure. However, the older age favored Candida gastric mucosa colonization, which could contribute to gastric pathologies and microbiome dysbiosis.

[1]  F. Mégraud,et al.  Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe , 2022, The American journal of gastroenterology.

[2]  H. Tilg,et al.  Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report , 2022, Gut.

[3]  Rui Xu,et al.  Fungal Microbiota Dysbiosis and Ecological Alterations in Gastric Cancer , 2022, Frontiers in Microbiology.

[4]  Song-Song Wang,et al.  Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents , 2022, Infection and drug resistance.

[5]  Ping Chen,et al.  Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric Diseases , 2022, BioMed research international.

[6]  Sixta L. Palencia,et al.  Multiple surface interaction mechanisms direct the anchoring, co-aggregation and formation of dual-species biofilm between Candida albicans and Helicobacter pylori , 2021, Journal of advanced research.

[7]  F. Mégraud,et al.  Empirical second-line therapy in 5,000 patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) , 2021, Clinical Gastroenterology and Hepatology.

[8]  M. Sugimoto,et al.  Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis , 2021, Frontiers in Pharmacology.

[9]  K. Sáez,et al.  Temperatures Outside the Optimal Range for Helicobacter pylori Increase Its Harboring within Candida Yeast Cells , 2021, Biology.

[10]  A. Fahim,et al.  Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs , 2021, Gastroenterology and hepatology from bed to bench.

[11]  T. Hohl,et al.  Mycobiota dysbiosis and gastric tumorigenesis , 2021, Theranostics.

[12]  Y. Yamaoka,et al.  Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications , 2021, Nature Reviews Gastroenterology & Hepatology.

[13]  V. Campos,et al.  Nutrient Deficiency Promotes the Entry of Helicobacter pylori Cells into Candida Yeast Cells , 2021, Biology.

[14]  K. Sáez,et al.  Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans ATCC10231 , 2021, Pathogens.

[15]  E. El-Omar,et al.  The interplay between Helicobacter pylori and gastrointestinal microbiota , 2021, Gut microbes.

[16]  K. Sáez,et al.  Intracellular Presence of Helicobacter pylori and Its Virulence-Associated Genotypes within the Vaginal Yeast of Term Pregnant Women , 2021, Microorganisms.

[17]  Kimberly Sánchez-Alonzo,et al.  Detection of Helicobacter pylori in oral yeasts from students of a Chilean university. , 2020, Revista da Associacao Medica Brasileira.

[18]  J. Gisbert Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review , 2020, Therapeutic advances in gastroenterology.

[19]  F. Mégraud,et al.  European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients , 2020, Gut.

[20]  Yong Xie,et al.  The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis , 2020, Helicobacter.

[21]  K. Sáez,et al.  In Vitro Incorporation of Helicobacter pylori into Candida albicans Caused by Acidic pH Stress , 2020, Pathogens.

[22]  J. Vítor,et al.  Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches , 2020, Microbial genomics.

[23]  J. Gisbert,et al.  Systematic review: gastric microbiota in health and disease , 2020, Alimentary pharmacology & therapeutics.

[24]  L. Kupčinskas,et al.  Distinct composition and distribution of the gastric mycobiota observed between dyspeptic and gastric cancer patients evaluated from gastric biopsies , 2020 .

[25]  Yunsheng Yang,et al.  Mucosa microbiome of gastric lesions: Fungi and bacteria interactions. , 2020, Progress in molecular biology and translational science.

[26]  M. Barone,et al.  Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness , 2019, World journal of gastroenterology.

[27]  I. Mitov,et al.  Multidrug resistance in Helicobacter pylori: current state and future directions , 2019, Expert review of clinical pharmacology.

[28]  N. Dash,et al.  Exploring the impact of Helicobacter pylori on gut microbiome composition , 2019, PloS one.

[29]  E. Touati,et al.  Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection. , 2019, Advances in experimental medicine and biology.

[30]  D. Graham,et al.  Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. , 2018, Gastroenterology.

[31]  M. Leja,et al.  Epidemiology of Helicobacter pylori infection , 2018, Helicobacter.

[32]  A. Cancino Candida sp. As a Potential Reservoir and Transmission Facilitator of Helicobacter Pylori , 2018 .

[33]  S. Mshana,et al.  The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis , 2018, BMC Infectious Diseases.

[34]  M. Upton,et al.  High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR , 2018, Helicobacter.

[35]  R. Alizadeh-Navaei,et al.  Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection , 2018, Alimentary pharmacology & therapeutics.

[36]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[37]  S. Moss The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer , 2016, Cellular and molecular gastroenterology and hepatology.

[38]  Jiaqi Deng,et al.  Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.

[39]  Antonio Gasbarrini,et al.  Antibiotics as deep modulators of gut microbiota: between good and evil , 2016, Gut.

[40]  F. Siavoshi,et al.  The Effect of Helicobacter pylori Infection, Aging, and Consumption of Proton Pump Inhibitor on Fungal Colonization in the Stomach of Dyspeptic Patients , 2016, Front. Microbiol..

[41]  G. Hung,et al.  Development of Candida-Specific Real-Time PCR Assays for the Detection and Identification of Eight Medically Important Candida Species , 2016, Microbiology insights.

[42]  Jason Y. Park,et al.  Review article: the global emergence of Helicobacter pylori antibiotic resistance , 2015, Alimentary pharmacology & therapeutics.

[43]  D. Scott,et al.  Gastric Colonization by H. pylori , 2016 .

[44]  H. E. Leylabadlo,et al.  Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. , 2015, World journal of methodology.

[45]  A. Gasbarrini,et al.  Gastric Microbiota , 2015, Helicobacter.

[46]  P. Malfertheiner,et al.  Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.

[47]  G. Nardone,et al.  The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? , 2015, United European gastroenterology journal.

[48]  F. Siavoshi,et al.  Vacuoles of Candida yeast as a specialized niche for Helicobacter pylori. , 2014, World journal of gastroenterology.

[49]  R. Malekzadeh,et al.  Localization of H.pylori within the vacuole of Candida yeast by direct immunofluorescence technique. , 2013, Archives of Iranian medicine.

[50]  K. Sasaki Candida-associated gastric ulcer relapsing in a different position with a different appearance. , 2012, World journal of gastroenterology.

[51]  V. Young,et al.  Interplay between the Gastric Bacterial Microbiota and Candida albicans during Postantibiotic Recolonization and Gastritis , 2011, Infection and Immunity.

[52]  C. Hassan,et al.  Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal. , 2011, World journal of gastrointestinal pathophysiology.

[53]  M. Zwolinska-Wcislo,et al.  Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[54]  C. Hassan,et al.  Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[55]  M. Vieira,et al.  Development and Application of a Novel Peptide Nucleic Acid Probe for the Specific Detection of Helicobacter pylori in Gastric Biopsy Specimens , 2007, Journal of Clinical Microbiology.

[56]  R. Malekzadeh,et al.  Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic patients. , 2006, The Journal of antimicrobial chemotherapy.

[57]  J. Stachura,et al.  Fungal colonization of gastric mucosa and its clinical relevance. , 2001, Medical science monitor : international medical journal of experimental and clinical research.

[58]  M. Blaser,et al.  Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. , 2001, Human pathology.

[59]  R. Ansorg,et al.  Adhesion of Helicobacter pylori to yeast cells. , 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[60]  中沢 俊二,et al.  胃疾患患者における Helicobacter pylori の検出状況 , 1996 .

[61]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[62]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.